Gapping up
In reaction to strong earnings/guidance:
In reaction to strong earnings/guidance:
- LPTH +18.3%, ASPU +3.9%, KANG +1.3%
Other news:
- MRTX +82.1% (presents 'positive' preliminary data from on-going clinical trials of sitravatinib in non-small cell lung cancer),
- TNXP +9.6% (receives a European patent protecting the use of Tonmya for the treatment of PTSD),
- OPNT +8.2% (provides an update on NARCAN Nasal Spray),
- MBOT +4.8% (announced that Intellectual Property India granted patent No. 286765, covering the Company's TipCAT technology platform),
- GNW +2.8% (Virginia State Corporation Commission, Bureau of Insurance, approved the proposed acquisition of control by Oceanwide of Genworth's Virginia-domiciled insurance companies),
- ARRY +2.8% (prices offering of 20,930,232 shares of its common stock at of $10.75 per share),
- OCLR +2.1% (initiated after hours with a Strong Buy at Raymond James),
- MRNS +1.7% (prices 9,333,334 common stock offering at $3.75/share),
- BTX +1.7% (ticking higher; announced the successful conclusion of the challenge to two key patents before the European Patent Office Opposition division),
- TWO +1.6% (Two Harbors Investment declared special dividend to distribute shares of Granite Point Mortgage Trust (GPMT) and approved a one-for-two reverse stock split), .
Analyst comments:
- FSLR +3.1% (upgraded to Buy from Hold at Deutsche Bank),
- WEN +2.3% (upgraded to Buy from Neutral at Longbow),
- OCLR +2.1% (initiated with a Strong Buy at Raymond James),
- NVDA +1.7% (target raised to $250 from $180 at Evercore ISI ),
- LUV +1.1% (upgraded to Overweight from Neutral at JP Morgan),